Newsroom

Vineti (formerly Vitruvian Networks)

December 6, 2017

News

Standards Coordinating Body and Nexight Group

The Need for Standards in Regenerative Medicine: Vineti Chief Strategy Officer Heidi Hagen to present at this webinar, sponsored by the SCB, on Dec 12

The Need for Standards in Regenerative Medicine: Vineti Chief Strategy Officer Heidi Hagen to present at this webinar, sponsored by the SCB, on Dec 12
October 25, 2017

News

How We Get to Next

The Human Machine of 2037 | A list of the ways the future will feel normal

The Human Machine of 2037 | A list of the ways the future will feel normal
October 25, 2017

News

Alliance for Regenerative Medicine and Pharma Intelliegence

CAR-T Approval: What's Next?: A webinar moderated by Heidi Hagen, Chief Strategy Officer, Vineti

CAR-T Approval: What's Next?: A webinar moderated by Heidi Hagen, Chief Strategy Officer, Vineti
October 24, 2017

News

Alliance for Regenerative Medicine

Cell and Gene Meeting on the Mesa, Plenary Session: Implications of Commercialization: What Does Approval Mean? (Moderated by Amy DuRoss, CEO, Vineti)

Cell and Gene Meeting on the Mesa, Plenary Session: Implications of Commercialization: What Does Approval Mean? (Moderated by Amy DuRoss, CEO, Vineti)
September 6, 2017

News

GlobeNewswire

Vineti expands its platform to support American Red Cross cellular therapy services

Vineti expands its platform to support American Red Cross cellular therapy services
August 31, 2017

News

Effective Commercialization through the Cloud

Vineti's Chief Strategy Officer Heidi Hagen to present at 2017 CAR-TCR Summit

Vineti's Chief Strategy Officer Heidi Hagen to present at 2017 CAR-TCR Summit
July 21, 2017

News

Biocentury

Accessing Miracles

Accessing Miracles
June 28, 2017

News

BioPharma-Reporter

Cloud-based platform for cell therapies to meet increased production levels

Cloud-based platform for cell therapies to meet increased production levels
June 26, 2017

News

San Francisco Business Times

Cell, gene therapies are hot. But can this startup make them safer?

Cell, gene therapies are hot. But can this startup make them safer?
June 22, 2017

News

FinSMEs

Vineti Raises $13.75M in Series A Funding

Vineti Raises $13.75M in Series A Funding
June 21, 2017

News

Post Bulletin

Mayo Clinic Ventures funds new cancer-fighting cell, gene therapy

Mayo Clinic Ventures funds new cancer-fighting cell, gene therapy
June 21, 2017

News

Becker's Health IT & CIO Review

Mayo Clinic, GE-backed startup secures $13.7M in Series A funding

Mayo Clinic, GE-backed startup secures $13.7M in Series A funding
June 21, 2017

News

Twin Cities Business

Mayo Backs Software Startup Looking to Accelerate Cancer Cure Process

Mayo Backs Software Startup Looking to Accelerate Cancer Cure Process
June 21, 2017

News

Contract Pharma

Vineti Receives $13.8M Investment in Drug Development Software Platform

Vineti Receives $13.8M Investment in Drug Development Software Platform
June 21, 2017

News

FierceBiotech

Vineti scores $13M+, launches cloud-based platform for cell therapies

Vineti scores $13M+, launches cloud-based platform for cell therapies
June 20, 2017

News

The Wall Street Journal

Vineti Takes Aim at Cancer Cell-Therapy Market With $13.8 Million Series A

Vineti Takes Aim at Cancer Cell-Therapy Market With $13.8 Million Series A
June 20, 2017

News

GlobeNewswire

GE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and Delivery

GE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and Delivery
June 20, 2017

News

MedCity News

GE Ventures spin-out Vineti raises $13.75M for complex biomanufacturing

GE Ventures spin-out Vineti raises $13.75M for complex biomanufacturing
June 20, 2017

News

TechCrunch

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market
January 12, 2017

News

Cell & Gene Therapy World

Vineti (formerly Vitruvian Networks) presents at Phacilitate Cell & Gene Therapy World 2017 Conference

Vineti (formerly Vitruvian Networks) presents at Phacilitate Cell & Gene Therapy World 2017 Conference
December 13, 2016

News

BusinessWire

Kite Pharma and Vineti (formerly Vitruvian Networks) Enter Strategic Partnership to Develop Best-In-Class Logistics and Data Analytics Software for Engineered T-cell Therapies at Commercial Scale

Kite Pharma and Vineti (formerly Vitruvian Networks) Enter Strategic Partnership to Develop Best-In-Class Logistics and Data Analytics Software for Engineered T-cell Therapies at Commercial Scale
October 4, 2016

News

Meeting on the Mesa

Vineti (formerly Vitruvian Networks) to present at Cell & Gene Meeting on the Mesa 2016

Vineti (formerly Vitruvian Networks) to present at Cell & Gene Meeting on the Mesa 2016
April 13, 2016

News

Vineti

Vineti (formerly Vitruvian Networks) proud to be an inaugural partner with Sean Parker’s $250M Institute for Cancer Immunotherapy

Vineti (formerly Vitruvian Networks) proud to be an inaugural partner with Sean Parker’s $250M Institute for Cancer Immunotherapy
April 11, 2016

News

GE Reports

New Digital Company Attacks Hard To Kill Cancer With Advanced Software And Manufacturing

New Digital Company Attacks Hard To Kill Cancer With Advanced Software And Manufacturing
April 11, 2016

News

GE

GE Ventures and Mayo Clinic Launch Company to Scale and Digitize Cell and Gene Therapies

GE Ventures and Mayo Clinic Launch Company to Scale and Digitize Cell and Gene Therapies